follitropin


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to follitropin: follitropin alpha, follitropin beta

follitropin

 [fol´ĭ-tro″pin]
follicle-stimulating hormone; follitropin alfa and follitropin beta are forms produced by genetically modified hamster cells and used in the treatment of infertility.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

fol·li·tro·pin

(fol'i-trō'pin),
An acidic glycoprotein hormone of the anterior pituitary that stimulates the graafian follicles of the ovary and assists subsequently in follicular maturation and the secretion of estradiol; in the male, it stimulates the epithelium of the seminiferous tubules and is partially responsible for inducing spermatogenesis.
Synonym(s): follicle-stimulating hormone, follicle-stimulating principle, gametokinetic hormone
[follicle + G. tropē, a turning, + -in]
Farlex Partner Medical Dictionary © Farlex 2012

fol·li·tro·pin

(fol'i-trō'pin)
An acidic glycoprotein hormone of the anterior pituitary that stimulates the ovarian follicles and promotes follicular maturation and the secretion of estradiol; in the male, it stimulates the epithelium of the seminiferous tubules and is partially responsible for inducing spermatogenesis.
Synonym(s): follicle-stimulating hormone.
[follicle + G. tropē, a turning, + -in]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
Mentioned in ?
References in periodicals archive ?
In 2006, the Recombinant Follitropin Beta injection by Merck Sharp & Dohme became the first Recombinant Follitropin Beta product approved to be sold in China.
Investigation Report on China's Recombinant Follitropin Beta Market, 2013-2018 & 2019-2023
According to the company, the GONAL-f RFF Redi-ject (follitropin alfa injection) is indicated for induction of ovulation and pregnancy in oligo-anovulatory women in whom the cause of infertility is functional and not due to primary ovarian failure and development of multiple follicles in ovulatory women as part of an Assisted Reproductive Technology (ART) cycle.
EMD Serono passes US FDA approval for new GONAL-f RFF Redi-ject fertility drug Pen
Effects of p,p'-DDT on follitropin (FSH)-stimulated cAMP production.
In vitro effects of the endocrine disruptor p,p'-DDT on human follitropin receptor
The Food and Drug Administration has approved the Follistim AQ Cartridge (follitropin beta injection).
FDA APPROVES FOLLISTIM AQ CARTRIDGE DELIVERED BY PEN DEVICE
The most widely prescribed gonadotropin, follitropin alfa for injection, has an 84% cumulative ovulation success rate, and the majority of patients using it have ovulated within three cycles.
Multiple Births Not Necessarily a Consequence of CONCEPTION DRUGS
ANTAGON adds to Organon's family of products for fertility: FOLLISTIM(R) (follitropin beta for injection), the first recombinant follicle stimulating hormone available in the United States for stimulating the development of follicles containing eggs; PREGNYL(R) (chorionic gonadotropin) for ovulation induction; and now ANTAGON for ovulation suppression.
FDA APPROVES ANTAGON FOR PREMATURE LEUTENIZING HORMONE SURGES
In addition to the discovery, development and manufacture of new biologies, the active pharmaceutical ingredient (API) for Rekovelle (follitropin delta), Ferring's latest fertility treatment, will be manufactured at the new Ferring Biotech Centre.
Ferring Pharmaceuticals To Open New Facility
The remaining 176 patients were treated with 300 IU follitropin alpha (Gonal-f; Merck, Switzerland) or follitropin beta (Puregon; NV Organon, Oss, Netherlands) subcutaneously on the second or third day of the cycle (group 2).
Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles/ Dusuk over yanitli hasta grubunda corifollitropin alfa ve rekombinant folikul uyarici hormonun in vitro fertilizasyon sikluslarinda karsilastirilmasi
The European Commission has granted marketing authorisation to Switzerland-based Ferring Pharmaceuticals for its REKOVELLE (follitropin delta), a human recombinant follicle stimulating hormone (human rFSH), intended to be used in controlled ovarian stimulation for developing multiple follicles in women undergoing assisted reproductive technologies, like an in vitro fertilisation or intracytoplasmic sperm injection cycle, it was reported yesterday.
Ferring Pharmaceuticals' REKOVELLE granted European Commission marketing authorisation
In addition, a starting dose of 112.5 IU of recombinant human follicle-stimulating hormone (follitropin alfa pen; Gonal-F, Merck Serono S.A., Geneva) was used with or without Menopur (Ferring, Germany) to induce ovulation.
Is coasting valuable in all patients with any cause of infertility?
Biological day-to-day variation and daytime changes of testosterone, follitropin, lutropin and oestradiol-17beta in healthy men.
Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the partnership for the accurate testing of hormones

Medical browser ?
Full browser ?